Skip to main content
SpringerLink
Log in

Ventricular Arrhythmias

  • Chapter
  • First Online:
FDG-PET/CT and PET/MR in Cardiovascular Diseases

  • 297 Accesses

Abstract

Ventricular arrhythmias (VA) are a major cause of morbidity and mortality especially in patients with structural heart disease. In the last decade, advanced imaging modalities such as cardiac magnetic resonance and nuclear imaging have progressively demonstrated a central role in the diagnosis and management of patients presenting with VA. In this setting, 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) is acquiring a growing role, thanks to its capability to the assess presence of inflammation and myocardial viability, thus improving our capability to clarify arrhythmic mechanisms, stratify patients risk, and identify potential targets for catheter ablation procedures. Here we describe the principles and main clinical applications of 18F-FDG PET imaging in the setting of VA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2016;38(22):1717–27.

    Google Scholar 

  2. Kumar S, Barbhaiya C, Nagashima K, Choi E-K, Epstein LM, John RM, Maytin M, Albert CM, Miller AL, Koplan BA, et al. Ventricular tachycardia in cardiac sarcoidosis characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93.

    Article  Google Scholar 

  3. Segawa M, Fukuda K, Nakano M, Kondo M, Satake H, Hirano M, Shimokawa H. Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2016;9:e003353.

    Article  CAS  Google Scholar 

  4. Tung R, Bauer B, Schelbert H, Lynch JP, Auerbach M, Gupta P, Schiepers C, Chan S, Ferris J, Barrio M, Ajijola O, Bradfield J, Shivkumar K. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis. Heart Rhythm. 2015;12:2488–98.

    Article  Google Scholar 

  5. Muser D, Santangeli P, Liang JJ, Castro SA, Magnani S, Hayashi T, Garcia FC, Frankel DS, Dixit S, Zado ES, Lin D, Desjardins B, Callans DJ, Alavi A, Marchlinski FE. Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation. JACC Clin Electrophysiol. 2018;4:291–303.

    Article  Google Scholar 

  6. Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–70.

    Article  CAS  Google Scholar 

  7. Budzianowski JK, Korybalska K, Bręborowicz A. The role of inflammation in cardiac arrhythmias pathophysiology. J Med Sci. 2016;85:197–204.

    Article  Google Scholar 

  8. Klein RM, Vester EG, Brehm MU, Dees H, Picard F, Niederacher D, Beckmann MW, Strauer BE. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol. 2000;89(Suppl 3):24–35.

    PubMed  Google Scholar 

  9. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 1989;32:217–38.

    Article  CAS  Google Scholar 

  10. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Hirata K, Nishimura M, Tamaki N. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23:244–52.

    Article  Google Scholar 

  11. Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA. 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI) and the European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging. 2020;21:1320–30.

    Article  Google Scholar 

  12. Choi Y, Brunken RC, Hawkins RA, Huang SC, Buxton DB, Hoh CK, Phelps ME, Schelbert HR. Factors affecting myocardial 2-[F-18] fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 1993;20:308–18.

    Article  CAS  Google Scholar 

  13. Iozzo P, Chareonthaitawee P, Di Terlizzi M, Betteridge DJ, Ferrannini E, Camici PG. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab. 2002;282:E1163–71.

    Article  CAS  Google Scholar 

  14. Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, Agrawal M, Madan R, Taqueti VR, Steigner M, Skali H, Kwong RY, Stewart GC, Dorbala S, Di Carli MF, Blankstein R. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11:e007030.

    Article  Google Scholar 

  15. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23:1187–226.

    Article  Google Scholar 

  16. DiFilippo FP, Brunken RC. Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT? J Nucl Med. 2005;46:436–43.

    PubMed  Google Scholar 

  17. Gormsen LC, Haraldsen A, Kramer S, Dias AH, Kim WY, Borghammer P. A dual tracer (68) Ga-DOTANOC PET/CT and (18) F-FDG PET/CT pilot study for detection of cardiac sarcoidosis. EJNMMI Res. 2016;6:52.

    Article  Google Scholar 

  18. Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68:411–21.

    Article  Google Scholar 

  19. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55.

    Google Scholar 

  20. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969–77.

    Article  Google Scholar 

  21. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2007;35:933–41.

    Article  Google Scholar 

  22. Muser D, Santangeli P, Pathak RK, Castro SA, Liang JJ, Magnani S, Hayashi T, Garcia FC, Hutchinson MD, Supple GE, et al. Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2016;9:e004333.

    Article  Google Scholar 

  23. Gowani Z, Habibi M, Okada DR, Smith J, Derakhshan A, Zimmerman SL, Misra S, Gilotra NA, Berger RD, Calkins H, Tandri H, Chrispin J. Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis. Am J Cardiol. 2020;134:123–9.

    Article  Google Scholar 

  24. Muser D, Santangeli P, Castro SA, Liang JJ, Enriquez A, Werner TJ, Nucifora G, Magnani S, Hayashi T, Zado ES, Garcia FC, Callans DJ, Dixit S, Desjardins B, Marchlinski FE, Alavi A. Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia. Eur J Nucl Med Mol Imaging. 2018;45(8):1–11.

    Article  Google Scholar 

  25. Lee P-I, Cheng G, Alavi A. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol. 2017;24:19–28.

    Article  Google Scholar 

  26. Lakkireddy D, Turagam MK, Yarlagadda B, Dar T, Hamblin M, Krause M, Parikh V, Bommana S, Atkins D, Di Biase L, Mohanty S, Rosamond T, Carroll H, Nydegger C, Wetzel L, Gopinathannair R, Natale A. Myocarditis causing premature ventricular contractions: insights from the MAVERIC registry. Circ Arrhythm Electrophysiol. 2019;12:e007520.

    Article  Google Scholar 

  27. Lakkireddy D, Yarlagadda B, Turagam M, Parikh A, Kola S, Hamblin M, Krause M, Rosamond T, Bommana S, Jaeger M, Carroll H, Nydegger C, Atkins D, Jeffery C, Gopinathannair R. B-LBCT02-02. Myocarditis is an underrecognized etiology of symptomatic premature ventricular contractions—insights from the myocarditis and ventricular arrhythmia (MAVERIC) registry. Heart Rhythm. 2018;15:942–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Electrophysiology, Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

    Daniele Muser & Pasquale Santangeli

  2. Nuclear Medicine Division, Radiology Department, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

    Abass Alavi

Authors
  1. Daniele Muser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abass Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pasquale Santangeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pasquale Santangeli .

Editor information

Editors and Affiliations

  1. Montreal Heart Institute, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

  2. BC Cancer Agency, Vancouver, BC, Canada

    Patrick Martineau

Ethics declarations

The authors have no disclosures.

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Muser, D., Alavi, A., Santangeli, P. (2022). Ventricular Arrhythmias. In: Pelletier-Galarneau, M., Martineau, P. (eds) FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09807-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-09807-9_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-09806-2

  • Online ISBN: 978-3-031-09807-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation